首页> 外文会议>International Conference on Biological Engineering and Pharmacy >Progress in Research on Small Molecules as Gene-targeted Drugs
【24h】

Progress in Research on Small Molecules as Gene-targeted Drugs

机译:小分子作为基因靶向药物的研究进展

获取原文

摘要

The findings of effective targets and the identification of target binding molecules are two key points in drug discovery. The complete human genome and their rapid increase in structural and functional information led to new possibilities for diagnosis and therapy of diseases, using gene-targeted drugs. Currently, gene-targeted drugs includes groove binders, intercalators, alkylators and cleavage agents and are widely used in cancer, Alzheimer's disease, blood pressure, heart and autoimmune diseases research and therapy. A review on the targeted genes, their interaction molecules and the application on disease therapy is presented.
机译:有效靶标的结果和靶结合分子的鉴定是药物发现中的两个关键点。 使用基因靶向药物,完整的人类基因组和结构和功能信息的快速增加导致了疾病的诊断和治疗的新可能性。 目前,基因靶向药物包括沟槽粘合剂,嵌入剂,烷基化剂和切割剂,并且广泛用于癌症,阿尔茨海默病,血压,心脏和自身免疫疾病研究和治疗。 介绍了靶向基因,它们的相互作用分子和疾病治疗施用的综述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号